Thomas Hochdörfer

Thomas Hochdörfer

AstraZeneca, Sweden - Södertälje / Sweden
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4403720
-
person_outline Thomas Hochdörfer's MOST POPULAR ARTICLES
1-) The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransportersDR Alessi, J Zhang, A Khanna, T Hochdörfer, Y Shang, KT KahleScience signaling 7 (334), re3-re3, 20142452014
2-) Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patientsC Winkler, T Hochdörfer, E Israelsson, A Hasselberg, A Cavallin, K Thörn, ...Journal of Allergy and Clinical Immunology 144 (1), 61-69. e7, 2019702019
3-) Expression of c‐Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cellsT Hochdörfer, C Winkler, K Pardali, J MjösbergEuropean journal of immunology 49 (6), 884-893, 2019692019
4-) Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cellsT Hochdörfer, M Kuhny, CN Zorn, RW Hendriks, B Vanhaesebroeck, ...Cellular signalling 23 (5), 866-875, 2011722011
5-) LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTPT Hochdörfer, C Tiedje, DJ Stumpo, PJ Blackshear, M Gaestel, M HuberCellular signalling 25 (6), 1339-1347, 2013422013